Back to Journals » Neuropsychiatric Disease and Treatment » Volume 7 » Issue 1

Neuropsychiatric Disease and Treatment


Archive: Volume 7, 2011

Attention deficits in Japanese multiple sclerosis patients with minor brain lesion loads

Takeda A, Nakajima M, Kobayakawa M, Tsuruya N, Koyama S, Miki T, Kawamura M

Neuropsychiatric Disease and Treatment 2011, 7:745-751

Published Date: 16 December 2011

Pregnancy is associated with psychiatric symptoms in a low-income countryside community of Brazil

Dias FMV, Junior CSD, Franco GC, Teixeira AL, Ribeiro AM

Neuropsychiatric Disease and Treatment 2011, 7:709-714

Published Date: 30 November 2011

Corrigendum

Sailasuta N, Harris K, Tran T, Ross B

Neuropsychiatric Disease and Treatment 2011, 7:707-708

Published Date: 25 November 2011

Exploration of sex differences in Rhes effects in dopamine mediated behaviors

Quintero GC, Spano D

Neuropsychiatric Disease and Treatment 2011, 7:697-706

Published Date: 17 November 2011

Predisposition for borderline personality disorder with comorbid major depression is associated with that for polycystic ovary syndrome in female Japanese population

Kawamura S, Maesawa C, Nakamura K, Nakayama K, Morita M, Hiruma Y, Yoshida T, Sakai A, Masuda T

Neuropsychiatric Disease and Treatment 2011, 7:655-662

Published Date: 1 November 2011

Polypharmacy or medication washout: an old tool revisited

Hoffman DA, Schiller M, Greenblatt JM, Iosifescu DV

Neuropsychiatric Disease and Treatment 2011, 7:639-648

Published Date: 20 October 2011

Clinical utility of the risperidone formulations in the management of schizophrenia

Madaan V, Bestha DP, Kolli VB, Jauhari S, Burket RC

Neuropsychiatric Disease and Treatment 2011, 7:611-620

Published Date: 18 October 2011

Current management of obsessive and phobic states

Goljevscek S, Carvalho LA

Neuropsychiatric Disease and Treatment 2011, 7:599-610

Published Date: 30 September 2011

Neuroimaging in eating disorders

Jáuregui-Lobera I

Neuropsychiatric Disease and Treatment 2011, 7:577-584

Published Date: 29 September 2011

Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting

Wallin ÅK, Wattmo C, Minthon L

Neuropsychiatric Disease and Treatment 2011, 7:565-576

Published Date: 30 September 2011

Retrospective chart review of a referenced EEG database in assisting medication selection for treatment of depression in patients with eating disorders

Greenblatt JM, Sussman C, Jameson M, Yuan L, Hoffman DA, Iosifescu DV

Neuropsychiatric Disease and Treatment 2011, 7:529-541

Published Date: 9 September 2011

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis

Warnke C, Stüve O, Hartung HP, Fogdell-Hahn A, Kieseier B

Neuropsychiatric Disease and Treatment 2011, 7:519-527

Published Date: 8 September 2011

Narcolepsy: a review

Akintomide GS, Rickards H

Neuropsychiatric Disease and Treatment 2011, 7:507-518

Published Date: 8 September 2011

An in vitro evaluation of guanfacine as a substrate for P-glycoprotein

Gillis NK, Zhu H-J, Markowitz JS

Neuropsychiatric Disease and Treatment 2011, 7:501-505

Published Date: 26 August 2011

Minimally invasive biomarker confirms glial activation present in Alzheimer's disease: a preliminary study

Sailasuta N, Harris K, Tran T, Ross B

Neuropsychiatric Disease and Treatment 2011, 7:495-499

Published Date: 24 August 2011

Moderate alcohol consumption and cognitive risk

Neafsey EJ, Collins MA

Neuropsychiatric Disease and Treatment 2011, 7:465-484

Published Date: 11 August 2011

APRESS: apical regulatory super system, serotonin, and dopamine interaction

Hinz M, Stein A, Uncini T

Neuropsychiatric Disease and Treatment 2011, 7:457-463

Published Date: 5 August 2011

Radioelectric brain stimulation in the treatment of generalized anxiety disorder with comorbid major depression in a psychiatric hospital: a pilot study

Olivieri E, Vecchiato C, Ignaccolo N, Mannu P, Castagna A, Aravagli L, Fontani V, Rinaldi S.

Neuropsychiatric Disease and Treatment 2011, 7:449-455

Published Date: 4 August 2011

Stress disorder and PTSD after burn injuries: a prospective study of predictors of PTSD at Sina Burn Center, Iran

Sadeghi-Bazargani H, Maghsoudi H, Soudmand-Niri M, Ranjbar F, Mashadi-Abdollahi H

Neuropsychiatric Disease and Treatment 2011, 7:425-429

Published Date: 13 July 2011

Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia

Chow TW, Graff-Guerrero A, Verhoeff NP, Binns MA, Tang-Wai DF, Freedman M, Masellis M, Black SE, Wilson AA, Houle S, Pollock BG

Neuropsychiatric Disease and Treatment 2011, 7:415-424

Published Date: 13 July 2011

Update on rufinamide in childhood epilepsy

Coppola G

Neuropsychiatric Disease and Treatment 2011, 7:399-407

Published Date: 5 July 2011

Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia

Louzã M, Elkis H, Ruschel S, de Oliveira IR, Bressan RA, Belmonte-de-Abreu P, Grabowski H, Appolinário JC

Neuropsychiatric Disease and Treatment 2011, 7:391-398

Published Date: 23 June 2011

Choking risk among psychiatric inpatients

Nagamine T

Neuropsychiatric Disease and Treatment 2011, 7:381-382

Published Date: 20 June 2011

Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor

Mannu P, Rinaldi S, Fontani V, Castagna A

Neuropsychiatric Disease and Treatment 2011, 7:373-379

Published Date: 15 June 2011

Remembering and forgetting: directed forgetting effect in obsessive-compulsive disorder

Konishi M, Shishikura K, Nakaaki S, Komatsu S, Mimura M

Neuropsychiatric Disease and Treatment 2011, 7:365-372

Published Date: 15 June 2011

Is serum brain-derived neurotrophic factor related to craving for or use of alcohol, cocaine, or methamphetamine?

Hilburn C, Nejtek VA, Underwood WA, Singh M, Patel G, Gangwani P, Forster MJ

Neuropsychiatric Disease and Treatment 2011, 7:357-364

Published Date: 21 June 2011

Investigation of insulin resistance in narcoleptic patients: dependent or independent of body mass index?

Engel A, Helfrich J, Manderscheid N, Musholt PB, Forst T, Pfützner A, Dahmen N

Neuropsychiatric Disease and Treatment 2011, 7:351-356

Published Date: 9 June 2011

Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence

McIntyre R, Yoon J, Jerrell JM, Liauw SS

Neuropsychiatric Disease and Treatment 2011, 7:319-323

Published Date: 25 May 2011

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands

Hoogveldt B, Rive B, Severens J, Maman K, Guilhaume C

Neuropsychiatric Disease and Treatment 2011, 7:313-317

Published Date: 15 June 2011

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder

Berman R, Thase M, Trivedi M, Hazel JA, Marler S, McQuade R, Carson W, Baker R, Marcus R

Neuropsychiatric Disease and Treatment 2011, 7:303-312

Published Date: 24 May 2011

Recurrent major depression, ataxia, and cardiomyopathy: association with a novel POLG mutation?

Verhoeven WMA, Egger JIM, Kremer BPH, de Pont BJHB, Marcelis CLM

Neuropsychiatric Disease and Treatment 2011, 7:293-296

Published Date: 15 May 2011

Risk factors for the development of depression in patients with hepatitis C taking interferon-α

Smith KJ, Norris S, O'Farrelly C, O'Mara SM

Neuropsychiatric Disease and Treatment 2011, 7:275-292

Published Date: 15 May 2011

The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder

Pompili M, Venturini P, Innamorati M , Serafini G, Telesforo L, Lester D, Tatarelli R, Girardi P

Neuropsychiatric Disease and Treatment 2011, 7:259-265

Published Date: 6 May 2011

A childhood case of symptomatic essential and psychogenic palatal tremor

Margari F, Giannella G, Lecce PA, Fanizzi P, Toto M, Margari L

Neuropsychiatric Disease and Treatment 2011, 7:223-227

Published Date: 27 April 2011

Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatients

Fornaro M, Maremmani I, Canonico PL, Carbonatto P, Mencacci C, Muscettola G, Pani L, Torta R, Vampini C, Parazzini F, Dumitriu A, Perugi G

Neuropsychiatric Disease and Treatment 2011, 7:217-221

Published Date: 21 April 2011

Screening for cognitive decline following single known stroke using the Mini-Mental State Examination

Arciniegas DB, Kellermeyer GF, Bonifer NM, Anderson-Salvi KM, Anderson CA

Neuropsychiatric Disease and Treatment 2011, 7:189-196

Published Date: 13 April 2011

Population-based study of acquired cerebellar ataxia in Al-Kharga district, New Valley, Egypt

Farghaly WMA, El-Tallawy HN, Shehata GA, Rageh TA, Abdel Hakeem N, Abo-Elfetoh NM

Neuropsychiatric Disease and Treatment 2011, 7:183-187

Published Date: 5 April 2011

Status epilepticus in the elderly: differential diagnosis and treatment

Mauricio EA, Freeman WD

Neuropsychiatric Disease and Treatment 2011, 7:161-166

Published Date: 29 March 2011

Current and emerging therapies for the treatment of myasthenia gravis

Renato Mantegazza, Silvia Bonanno, Giorgia Camera, et al

Neuropsychiatric Disease and Treatment 2011, 7:151-160

Published Date: 22 March 2011

Pharmacotherapy for treatment-resistant schizophrenia

Meghan E Mcilwain, Jeff Harrison, Amanda J Wheeler, et al

Neuropsychiatric Disease and Treatment 2011, 7:135-149

Published Date: 17 March 2011

Performance of Cpred/Cobs concentration ratios as a metric reflecting adherence to antidepressant drug therapy

Yan Feng, Marc R Gastonguay, Bruce G Pollock, et al

Neuropsychiatric Disease and Treatment 2011, 7:117-125

Published Date: 17 March 2011

Psychiatric disorders in primary focal dystonia and in Parkinson’s disease

Fernando MV Dias, Arthur Kummer, Flávia CP Doyle, et al

Neuropsychiatric Disease and Treatment 2011, 7:111-116

Published Date: 14 March 2011

Do neurologists in Germany adhere to the national Parkinson's disease guideline?

Sabrina Schröder, Daniel Kuessner, Guy Arnold, et al

Neuropsychiatric Disease and Treatment 2011, 7:103-110

Published Date: 7 March 2011

Brain volumetric measures in alcoholics: a comparison of two segmentation methods

Marlene Oscar-Berman, Janet Song

Neuropsychiatric Disease and Treatment 2011, 7:65-75

Published Date: 27 February 2011

The relationship between insomnia and depressive symptoms: genuine or artifact?

Fadia Isaac, Kenneth Mark Greenwood

Neuropsychiatric Disease and Treatment 2011, 7:57-63

Published Date: 14 February 2011

Evidence to practice: treatment of anxiety in individuals with autism spectrum disorders

Russell Lang, Richard Mahoney, Farah El Zein, et al

Neuropsychiatric Disease and Treatment 2011, 7:27-30

Published Date: 25 January 2011

The societal costs of insomnia

Alan G Wade

Neuropsychiatric Disease and Treatment 2011, 7:1-18

Published Date: 20 December 2010